IBO IMPACT BIOMEDICAL INC.

NYSE www.impactbiomedinc.com


$ 0.58 $ -0.01 (-0.93 %)    

Tuesday, 21-Oct-2025 19:28:27 EDT
QQQ $ 610.41 $ -0.16 (-0.03 %)
DIA $ 469.29 $ 2.20 (0.47 %)
SPY $ 671.10 $ -0.01 (0 %)
TLT $ 92.01 $ 0.45 (0.49 %)
GLD $ 379.40 $ -25.91 (-6.43 %)
$ 0.5846
$ 0.60
$ 0.58 x 739
$ 0.61 x 5,000
$ 0.58 - $ 0.60
$ 0.36 - $ 6.17
108,481
na
7.12M
$ 3.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 02-20-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $7.00 thousand in sales this...

Core News & Articles

On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into a Debt Conversion Agreement...

 impact-biomedical-stock-is-soaring-monday-whats-going-on

Impact Biomedical, Inc. (AMEX:IBO) stock is trading higher Monday after the company announced a limited merger and share exchan...

Core News & Articles

Key Transaction TermsUnder the terms of the Merger Agreement, a merger subsidiary incorporated in Nevada as a PubCo subsidiary ...

Core News & Articles

Dr Ashleys Limited, a Hong Kong based global pharmaceutical company ("Dr Ashleys"), and Impact BioMedical Inc. ("Im...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION